POLARISqb and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, today announced a collaboration to study oncology targets currently considered undruggable. Under the terms of the agreement, the POLARISqb Tachyon™ quantum computing platform will be used to scan billions of molecules from a large chemical…
![POLARISqb and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies](https://polarisqb.com/wp-content/uploads/2022/01/Polaris-Phoremost-375x206.png)